These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2927178)

  • 1. Childhood acute promyelocytic leukemia: a rare variant of nonlymphoid leukemia with distinctive clinical and biologic features.
    Carter M; Kalwinsky DK; Dahl GV; Santana VM; Mason CA; Schell MJ
    Leukemia; 1989 Apr; 3(4):298-302. PubMed ID: 2927178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics and treatment results of acute promyelocytic leukemia in children (Children's Cancer and Leukemia Study Group)].
    Shimizu H; Nakadate H; Taga T; Utsumi J; Nishikawa K; Gushiken T; Horikoshi Y; Oka T; Kikuta A; Maeda H
    Rinsho Ketsueki; 1993 Sep; 34(9):989-96. PubMed ID: 8230751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
    Bassan R; Battista R; Viero P; d'Emilio A; Buelli M; Montaldi A; Rambaldi A; Tremul L; Dini E; Barbui T
    Leukemia; 1995 Feb; 9(2):238-43. PubMed ID: 7869758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of patients with acute promyelocytic leukemia. The EORTC-LCG experience. EORTC Leukemia Cooperative Group.
    Willemze R; Suciu S; Mandelli F; de Witte T; Cadiou M; Castoldi GL; Liso V; Dardenne M; Solbu G; Zittoun R
    Leukemia; 1994; 8 Suppl 2():S48-55. PubMed ID: 7815837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M; López Fernández MF; Batlle J
    Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors].
    Schwarz J; Korístek Z; Starý J; Zák P; Kozák T; Marková J; Michalová K; Dvoráková D; Mayer J; Cetkovský P
    Vnitr Lek; 2008; 54(7-8):757-70. PubMed ID: 18780575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.
    Bally C; Fadlallah J; Leverger G; Bertrand Y; Robert A; Baruchel A; Guerci A; Recher C; Raffoux E; Thomas X; Leblanc T; Idres N; Cassinat B; Vey N; Chomienne C; Dombret H; Sanz M; Fenaux P; Adès L
    J Clin Oncol; 2012 May; 30(14):1641-6. PubMed ID: 22473162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.
    Eardley AM; Heller G; Warrell RP
    Leukemia; 1994 Jun; 8(6):934-9. PubMed ID: 8207987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial of daunomycin in acute promyelocytic leukemia of childhood: a Southwest Oncology Group Study.
    van Eys J; Steuber P; Haggard ME; Sabio H; Duncan M
    Am J Pediatr Hematol Oncol; 1981; 3(3):301-3. PubMed ID: 7025685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
    Ventura GJ; Hester JP; Dixon DO; Khorana S; Keating MJ
    Hematol Pathol; 1989; 3(1):23-8. PubMed ID: 2745357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction and maintenance therapy in all-trans retinoic acid with relapsed acute promyelocytic leukemia].
    Takitani K; Kawamura N; Yamaguchi H; Morinobu W; Yoshida N; Watanabe K; Miyake M; Tatsumi K; Mino M
    Rinsho Ketsueki; 1995 Feb; 36(2):147-52. PubMed ID: 7715086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. The Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho).
    Fukutani H; Naoe T; Ohno R; Yoshida H; Miyawaki S; Shimazaki C; Miyake T; Nakayama Y; Kobayashi H; Goto S
    Leukemia; 1995 Sep; 9(9):1478-82. PubMed ID: 7658715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
    Esteve J; Escoda L; Martín G; Rubio V; Díaz-Mediavilla J; González M; Rivas C; Alvarez C; González San Miguel JD; Brunet S; Tomás JF; Tormo M; Sayas MJ; Sánchez Godoy P; Colomer D; Bolufer P; Sanz MA;
    Leukemia; 2007 Mar; 21(3):446-52. PubMed ID: 17205057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular coagulation and fibrinolysis syndrome (ICF) in acute non-promyelocytic leukemia.
    Kotschy M; Kotlarek-Haus S; Podolak-Dawidziak M; Nowicka J; Dzik T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):65-73. PubMed ID: 6157626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S; Ullah K; Ahmed P; Khan B
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP).
    Biondi A; Rovelli A; Cantù-Rajnoldi A; Fenu S; Basso G; Luciano A; Rondelli R; Mandelli F; Masera G; Testi AM
    Leukemia; 1994 Aug; 8(8):1264-8. PubMed ID: 8057659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study.
    Imaizumi M; Tawa A; Hanada R; Tsuchida M; Tabuchi K; Kigasawa H; Kobayashi R; Morimoto A; Nakayama H; Hamamoto K; Kudo K; Yabe H; Horibe K; Tsuchiya S; Tsukimoto I
    Br J Haematol; 2011 Jan; 152(1):89-98. PubMed ID: 20735397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.